中国药房2012，Vol.23Issue(16)：1459-1463,5.DOI:10.6039/j.issn.1001-0408.2012.16.07
2011年四川省基本药物集中招标中标品种分析
Analysis on the Bidding Drug Varieties in the Centralized Bidding of Essential Drug in Sichuan Province in 2011
摘要
Abstract
OBJECTIVE: To provide reference for the improvement of centralized bidding and purchase system of essential drugs. METHODS: 1~4 batches of the bidding essential drugs announced on the website of Sichuan provincial health department were analyzed statistically in terms of specification, manufacturers and prices. RESULTS: 1~4 batches of bidding drugs including 871 specifications were announced by Sichuan provincial health department in 2011. 34 drugs in essential drug list (EML) lost the bid, 354 manufacturers won the bid, the bidding number varied froml to 28. The price of bidding chemical drugs ranged 0.07~ 52.7 yuan with medium price of 2.5 yuan, Chinese patent drugs 0.18~84 yuan with medium price of 7.5 yuan. The lowest price of bidding drug was only 1/20.1 of government referential price, and the highest was 1/1.2 of referential price. CONCLUSION: Variety and enterprise distribution of bidding essential drugs are reasonable in Sichuan province relatively; inappropriate EML and other reasons result in lost the bid. The unreasonable low price of bidding drugs would lead to the difficulty of long-term implementation of nation essential drug system. It is suggested to establish long-term mechanism of essential drug system and formulate suitable supplemental variety and reasonable bidding and purchase plan.关键词
基本药物/集中招标/中标品种/价格Key words
Essential drugs: Centralized bidding/ Bidding drugs/ Price分类
医药卫生引用本文复制引用
杨林,胡明,吴佳怡,吴江玥,周乃彤..2011年四川省基本药物集中招标中标品种分析[J].中国药房,2012,23(16):1459-1463,5.基金项目
国家自然科学基金资助项目(71103125) （71103125）
四川省发展和改革委员会2011年省级重点课题(ZH2011007) （ZH2011007）
